Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis

The Nazareth Hospital, Israel

Status: Completed

Conditions: Adrenal Suppression

Study type: Observational

Funder types: Other

Identifiers

NCT01799408

HPA-2012

Details and patient eligibility

About

To evaluate the effect of intra-articular corticosteroid injection (IACI) of depot preparation of betamethasone on the hypothalamic-pituitary-adrenal (HPA) axis, in patients with osteoarthritis of the knee

Full description

Consecutive patients attending the rheumatology or orthopedic clinic with osteoarthritic knee pain, not responding satisfactorily to medical or physical therapy were allocated to group-1 after consent and given IACI of 6 mg of betamethasone acetate/betamethasone sodium phosphate. Following completion of this part, consecutive age- and sex-matched patients were allocated to group-2 and given intra-articular injection of 60 mg of sodium hyaluronate. Just prior to the knee injection and 1, 2, 3, 4 and 8 weeks later, patients had 1 µg adrenocorticotropin hormone (ACTH) stimulation test. Secondary adrenal insufficiency (SAI) was defined as levels of less than 18 ng/ml or a rise of < than 7 ng/ml of serum cortisol, 30 minutes following the ACTH stimulation test.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Osteoarthritis of the knee

Exclusion criteria

• Had steroids in the last 3 months. Allergic to steroids

Trial design

40 participants in 2 patient groups

betamethasone

Description:

Patients who had intra-articular injection of betamethasone

Hyaluronic acid

Description:

Patients who had intra-articular injection of hyaluronic acid